Albany Molecular Research
1
3M
1
0.03
- Areas of investment
Summary
In 1991 was created Albany Molecular Research, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Albany. The fund was located in North America if to be more exact in United States.
Among the most popular fund investment industries, there are Chemical, Chemical Engineering. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Fluorous Technologies.
The common things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2003. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Innovation Works, Fairview Capital Partners, Alfred Bader.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.03
- Investments by industry
- Chemical Engineering (1)
- Advanced Materials (1)
- Chemical (1)
- Investments by region
- United States (1)
- Peak activity year
- 2003
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Fluorous Technologies | 30 Jun 2003 | Chemical, Advanced Materials, Chemical Engineering | Early Stage Venture | 3M | United States, Pennsylvania |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.